Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Patient Education and Counseling|April 11, 2025
Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancerLisa Dwyer Orr, Julie Vanderpoel, Pratyusha Vadagam, et al.
Oncotarget|August 17, 2016
PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activityUpal Basu-Roy, Eugenia Han, Kirk Rattanakorn, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung CancerPhil Bonomi, Nina Stuccio, C J Delgra, et al.
Chest|June 28, 2021
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung CancerAdam H Fox, James R Jett, Upal Basu Roy, et al.
Blood|April 4, 2014
Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinctUma Mahesh Gundra, Natasha M Girgis, Dominik Ruckerl, et al.
Molecular Cell|December 22, 2015
Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase CγZhifeng Huang, William M Marsiglia, Upal Basu Roy, et al.
The Journal of Clinical Investigation|September 20, 2016
Angiotensin receptors and β-catenin regulate brain endothelial integrity in malariaJulio Gallego-Delgado, Upal Basu-Roy, Maureen Ty, et al.
Clinical Lung Cancer|March 24, 2020
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working GroupPatrick M Forde, Phil Bonomi, Alice Shaw, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2025
The 2024 International Association for the Study of Lung Cancer Global Survey on Biomarker TestingMatthew P Smeltzer, Jennifer C King, Casey Connolly, et al.
Cancer Medicine|December 18, 2021
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologistsKathryn F Mileham, Caroline Schenkel, Suanna S Bruinooge, et al.
Pageof 4